Hims & Hers is making a major global expansion with its planned acquisition of Australian digital health company Eucalyptus, a good move for the company as it faces regulatory and legal challenges in the U.S. over its sale of compounded GLP-1s, experts say. This is a smart deal for Hims & Hers, according to Michael Abrams, managing partner of Numerof & Associates. The companies are highly complementary as they both provide services that include men’s health, women’s health, weight health and dermatology. They also both share a mission of expanding personalized, consumer-focused healthcare.
Read the full article: What Experts Say About Hims & Hers’ $1.15B Acquisition of Eucalyptus //
Source: https://medcitynews.com/2026/02/hims-hers-acquisition-eucalyptus/